Capital International Investors Cuts Guardant Health Stake to 3.8%

Ticker: GH · Form: SC 13G/A · Filed: 2024-02-09T00:00:00.000Z

Sentiment: bearish

Topics: institutional-ownership, stake-reduction, amendment, investor-sentiment

TL;DR

**Big investor just trimmed their Guardant Health shares, watch for potential dip.**

AI Summary

Capital International Investors, a Delaware-based investment firm, filed an amended SC 13G/A on February 9, 2024, disclosing its ownership in Guardant Health, Inc. As of December 29, 2023, the firm beneficially owned 4,013,661 shares of Guardant Health's Common Stock, representing 3.8% of the company. This filing indicates a decrease in their stake from a previous disclosure, which could signal a shift in their investment strategy or a rebalancing of their portfolio, potentially impacting investor sentiment for Guardant Health stock.

Why It Matters

This filing shows a major institutional investor, Capital International Investors, has reduced its stake in Guardant Health, which could be interpreted negatively by the market and potentially lead to downward pressure on the stock price.

Risk Assessment

Risk Level: medium — A significant institutional investor reducing its stake can signal a lack of confidence or a re-evaluation of the company's prospects, posing a moderate risk to current and prospective shareholders.

Analyst Insight

A smart investor would monitor Guardant Health's stock performance closely and research the reasons behind Capital International Investors' reduced stake, considering if this signals a broader negative outlook before making any investment decisions.

Key Numbers

4,013,661 — shares beneficially owned (This is the total number of Guardant Health shares Capital International Investors had sole voting and dispositive power over as of December 29, 2023.)
3.8% — percentage of class (This represents the ownership percentage of Guardant Health's Common Stock held by Capital International Investors, indicating a reduction from previous filings.)

Key Players & Entities

Capital International Investors (company) — the reporting person who filed the SC 13G/A
Guardant Health, Inc. (company) — the subject company whose securities are being reported
Delaware (company) — place of organization for Capital International Investors
December 29, 2023 (date) — date of the event which required the filing
February 9, 2024 (date) — date the SC 13G/A amendment was filed

Forward-Looking Statements

Guardant Health's stock price may experience short-term downward pressure. (Guardant Health, Inc.) — medium confidence, target: Within 1-3 months

FAQ

Who filed this SC 13G/A amendment?

The SC 13G/A amendment was filed by Capital International Investors, a company organized in Delaware with IRS Identification No. 95-1411037.

What is the subject company of this filing?

The subject company is Guardant Health, Inc., a medical laboratories service company with the Central Index Key (CIK) 0001576280, located at 3100 Hanover Street, Palo Alto, CA.

What was the date of the event that triggered this filing?

The date of the event which required the filing of this statement was December 29, 2023, as stated on the cover page of the Schedule 13G.

How many shares of Guardant Health, Inc. Common Stock does Capital International Investors beneficially own?

As of December 29, 2023, Capital International Investors beneficially owns 4,013,661 shares of Guardant Health, Inc. Common Stock, with sole voting and dispositive power over these shares.

What percentage of Guardant Health's Common Stock does Capital International Investors now own?

Capital International Investors now owns 3.8% of Guardant Health, Inc.'s Common Stock, as indicated in Item 13 of the filing, which is a decrease from previous holdings.

From the Filing

0001422848-24-000135.txt : 20240209 0001422848-24-000135.hdr.sgml : 20240209 20240209180324 ACCESSION NUMBER: 0001422848-24-000135 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90826 FILM NUMBER: 24616608 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Capital International Investors CENTRAL INDEX KEY: 0001562230 ORGANIZATION NAME: IRS NUMBER: 951411037 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 FORMER COMPANY: FORMER CONFORMED NAME: Capital Research & Management Co - Division 3 DATE OF NAME CHANGE: 20121114 SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 ) * Guardant Health, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 40131M109 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 40131M109 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Capital International Investors 95-1411037 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 4,013,661 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 4,013,661 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,013,661 Beneficial ownership disclaimed pursuant to Rule 13d-4 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.4% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer Guardant Health, Inc. (b) Address of Issuer's Principal Executive Offices 3100 Hanover Street, Palo Alto, CA 94304 Item 2. (a) Name of Person Filing Capital International Investors (b) Address of Principal Business Office or, if None, Residence 333 South Hope Street, 55th Fl, Los Angeles, CA 90071 (c) Citizenship N/A (d) Title of Class of Securities Common Stock (e) CUSIP Number 40131M109 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of